

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59330775 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.59330775 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27861729 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.27861729 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.78104812 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.43448363 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.09416982 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.09416982 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.09416982 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.04886148 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.96167362 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 5.89674766 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.84849467 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.75990973 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.75060012 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.71276088 |
| 17 | urea metabolic process (GO:0019627) | 5.62966859 |
| 18 | urea cycle (GO:0000050) | 5.62966859 |
| 19 | exogenous drug catabolic process (GO:0042738) | 5.57699320 |
| 20 | cysteine metabolic process (GO:0006534) | 5.51960702 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44179991 |
| 22 | regulation of apoptotic cell clearance (GO:2000425) | 5.42254028 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.39792847 |
| 24 | protein carboxylation (GO:0018214) | 5.39471198 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39471198 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.35185469 |
| 27 | * negative regulation of fibrinolysis (GO:0051918) | 5.31300243 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.26247159 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.22413880 |
| 30 | * regulation of fibrinolysis (GO:0051917) | 5.22120118 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.17838529 |
| 32 | omega-hydroxylase P450 pathway (GO:0097267) | 5.17357606 |
| 33 | reverse cholesterol transport (GO:0043691) | 5.08658395 |
| 34 | negative regulation of protein activation cascade (GO:2000258) | 5.04131003 |
| 35 | bile acid metabolic process (GO:0008206) | 4.98205809 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.96478120 |
| 37 | regulation of complement activation (GO:0030449) | 4.96444129 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.93634430 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.93406900 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91789336 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.91789336 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.91789336 |
| 43 | protein-lipid complex subunit organization (GO:0071825) | 4.91372525 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.86158012 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.79966658 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.77893756 |
| 47 | regulation of humoral immune response (GO:0002920) | 4.75684008 |
| 48 | lysine metabolic process (GO:0006553) | 4.74742626 |
| 49 | lysine catabolic process (GO:0006554) | 4.74742626 |
| 50 | phospholipid efflux (GO:0033700) | 4.69245629 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.67963971 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.67963971 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.66248739 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.65577906 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.61320537 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.57849893 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.57849893 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.55240550 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.54764329 |
| 60 | * acute-phase response (GO:0006953) | 4.48743165 |
| 61 | glycine metabolic process (GO:0006544) | 4.45479505 |
| 62 | * negative regulation of hemostasis (GO:1900047) | 4.45193837 |
| 63 | * negative regulation of blood coagulation (GO:0030195) | 4.45193837 |
| 64 | * regulation of plasminogen activation (GO:0010755) | 4.34381164 |
| 65 | cholesterol efflux (GO:0033344) | 4.33315404 |
| 66 | ethanol metabolic process (GO:0006067) | 4.32625301 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.32278621 |
| 68 | glutamate metabolic process (GO:0006536) | 4.32031091 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.30955458 |
| 70 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.30530760 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 4.30190431 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 4.28958596 |
| 73 | coenzyme catabolic process (GO:0009109) | 4.26803675 |
| 74 | bile acid and bile salt transport (GO:0015721) | 4.26576844 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.21994765 |
| 76 | amine catabolic process (GO:0009310) | 4.21994765 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 4.18597748 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 4.17721773 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 4.17267202 |
| 80 | cellular glucuronidation (GO:0052695) | 4.11637518 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.09963563 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09289231 |
| 83 | aldehyde catabolic process (GO:0046185) | 4.07776138 |
| 84 | * negative regulation of coagulation (GO:0050819) | 4.06013999 |
| 85 | arginine metabolic process (GO:0006525) | 4.04983507 |
| 86 | drug catabolic process (GO:0042737) | 4.04761865 |
| 87 | negative regulation of complement activation (GO:0045916) | 4.03466988 |
| 88 | proline metabolic process (GO:0006560) | 4.03000592 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02232347 |
| 90 | ethanol oxidation (GO:0006069) | 3.99377419 |
| 91 | lipoprotein metabolic process (GO:0042157) | 3.98322645 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97242427 |
| 93 | ketone body metabolic process (GO:1902224) | 3.93622554 |
| 94 | * negative regulation of wound healing (GO:0061045) | 3.92767648 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91410390 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91410390 |
| 97 | cytolysis (GO:0019835) | 3.90989595 |
| 98 | * positive regulation of hemostasis (GO:1900048) | 3.90686140 |
| 99 | * positive regulation of blood coagulation (GO:0030194) | 3.90686140 |
| 100 | drug metabolic process (GO:0017144) | 3.83125023 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.82739703 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.80643493 |
| 103 | cholesterol transport (GO:0030301) | 3.77313735 |
| 104 | sterol transport (GO:0015918) | 3.77313735 |
| 105 | cofactor catabolic process (GO:0051187) | 3.76945173 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76703394 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.76208794 |
| 108 | organic acid catabolic process (GO:0016054) | 3.76060553 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.76060553 |
| 110 | sterol homeostasis (GO:0055092) | 3.74894771 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.74723055 |
| 112 | * fibrinolysis (GO:0042730) | 3.74266868 |
| 113 | intestinal absorption (GO:0050892) | 3.74212746 |
| 114 | protein-lipid complex assembly (GO:0065005) | 3.74204731 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 3.72598465 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.72220941 |
| 117 | protein activation cascade (GO:0072376) | 3.71414334 |
| 118 | complement activation, classical pathway (GO:0006958) | 3.69191556 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.67385723 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.67385723 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.66660718 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66373401 |
| 123 | complement activation (GO:0006956) | 3.65685396 |
| 124 | acetyl-CoA metabolic process (GO:0006084) | 3.64137752 |
| 125 | urate metabolic process (GO:0046415) | 3.63229005 |
| 126 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.59286796 |
| 127 | drug transmembrane transport (GO:0006855) | 3.57406778 |
| 128 | heme transport (GO:0015886) | 3.56550472 |
| 129 | * positive regulation of coagulation (GO:0050820) | 3.54898278 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.51503707 |
| 131 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.51503707 |
| 132 | opsonization (GO:0008228) | 3.45208556 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 3.43966549 |
| 134 | positive regulation of steroid metabolic process (GO:0045940) | 3.36860090 |
| 135 | peptidyl-glutamic acid modification (GO:0018200) | 3.36810287 |
| 136 | negative regulation of lipid transport (GO:0032369) | 3.34893987 |
| 137 | regulation of lipoprotein particle clearance (GO:0010984) | 3.34224520 |
| 138 | diacylglycerol metabolic process (GO:0046339) | 3.34010435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38858631 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20936282 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92866150 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47936613 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23913651 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13176280 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89557280 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03294317 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01728932 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08490706 |
| 11 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04674491 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0968788 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.99235841 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98991121 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62129332 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57258156 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52787151 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47916527 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43499020 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34949477 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33429017 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20618715 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18007076 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13479006 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11434840 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09901401 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09804536 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07034657 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05306108 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03825588 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00271515 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93868509 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93733637 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91833456 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89685165 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89213597 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89176894 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87991151 |
| 39 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.86608383 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86156716 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85129357 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83408333 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82768730 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82676959 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82667135 |
| 46 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81703528 |
| 47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79973091 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78489309 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76575309 |
| 50 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75199256 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74224297 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74207963 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73255833 |
| 54 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72371035 |
| 55 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71595023 |
| 56 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71508855 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69325672 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68010737 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67660407 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67367757 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67125411 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66750106 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66355707 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66068521 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65652725 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65633536 |
| 67 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.64904187 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63743892 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62802254 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62404122 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.62366304 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.62309312 |
| 73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.62173163 |
| 74 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61146267 |
| 75 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60757275 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.60560671 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60286730 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58798306 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58695990 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58695990 |
| 81 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.58683521 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.58520297 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58029498 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57132948 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.56112413 |
| 86 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.55290355 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.54316050 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53835708 |
| 89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.53762585 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53734137 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.53458025 |
| 92 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53245246 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53156767 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.52791805 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52401432 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52216950 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51975853 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.51677394 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51589905 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.51568565 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51259458 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50943645 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49959165 |
| 104 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.49689986 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.47603395 |
| 106 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47249767 |
| 107 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46860192 |
| 108 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46579863 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46054131 |
| 110 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45576092 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45138444 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44840121 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44668601 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44264339 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43495200 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43033284 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42694701 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42587257 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41693731 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40622415 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39843207 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39482884 |
| 123 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37822342 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35642660 |
| 125 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35360014 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.35040740 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.34911811 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.34715394 |
| 129 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34641731 |
| 130 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34598386 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.34495083 |
| 132 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34488522 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33763782 |
| 134 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33584717 |
| 135 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.33469645 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.33429795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21624853 |
| 2 | MP0005360_urolithiasis | 7.65962296 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.32652166 |
| 4 | MP0005365_abnormal_bile_salt | 6.09151285 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.98332230 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.20182745 |
| 7 | MP0003252_abnormal_bile_duct | 3.86499799 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59921587 |
| 9 | MP0009840_abnormal_foam_cell | 3.30643119 |
| 10 | MP0005083_abnormal_biliary_tract | 3.08946109 |
| 11 | MP0003195_calcinosis | 2.90490078 |
| 12 | MP0005332_abnormal_amino_acid | 2.88359584 |
| 13 | MP0003122_maternal_imprinting | 2.72778688 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.57318892 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.49866372 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.29107456 |
| 17 | MP0000609_abnormal_liver_physiology | 2.16276980 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.08831451 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.08775560 |
| 20 | MP0000566_synostosis | 1.96405678 |
| 21 | MP0003868_abnormal_feces_composition | 1.83711470 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.83523216 |
| 23 | MP0001764_abnormal_homeostasis | 1.69558613 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59973022 |
| 25 | MP0009697_abnormal_copulation | 1.55399726 |
| 26 | MP0001915_intracranial_hemorrhage | 1.54364204 |
| 27 | MP0002132_abnormal_respiratory_system | 1.54252214 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.54070694 |
| 29 | MP0003011_delayed_dark_adaptation | 1.46113851 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.44099801 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.43922695 |
| 32 | MP0005451_abnormal_body_composition | 1.42795976 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.36579967 |
| 34 | MP0003186_abnormal_redox_activity | 1.31701050 |
| 35 | MP0003123_paternal_imprinting | 1.28997815 |
| 36 | MP0000598_abnormal_liver_morphology | 1.19714672 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.15473073 |
| 38 | MP0000604_amyloidosis | 1.12971967 |
| 39 | MP0005647_abnormal_sex_gland | 1.08630189 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.08130245 |
| 41 | MP0009764_decreased_sensitivity_to | 1.04936187 |
| 42 | MP0002254_reproductive_system_inflammat | 1.02697962 |
| 43 | MP0009763_increased_sensitivity_to | 1.01549695 |
| 44 | MP0010368_abnormal_lymphatic_system | 0.99723808 |
| 45 | MP0008469_abnormal_protein_level | 0.90644809 |
| 46 | * MP0009642_abnormal_blood_homeostasis | 0.88579239 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.88504270 |
| 48 | MP0005408_hypopigmentation | 0.87065000 |
| 49 | MP0005409_darkened_coat_color | 0.86364994 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.86105284 |
| 51 | MP0003879_abnormal_hair_cell | 0.82297278 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.80759046 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.78256869 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.78005327 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.77578501 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.76781183 |
| 57 | MP0004272_abnormal_basement_membrane | 0.76205354 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.75624202 |
| 59 | MP0005670_abnormal_white_adipose | 0.73924346 |
| 60 | MP0002971_abnormal_brown_adipose | 0.70129360 |
| 61 | MP0001756_abnormal_urination | 0.69821855 |
| 62 | MP0002282_abnormal_trachea_morphology | 0.69115413 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.69101894 |
| 64 | MP0001661_extended_life_span | 0.68585345 |
| 65 | MP0009053_abnormal_anal_canal | 0.67371225 |
| 66 | MP0005535_abnormal_body_temperature | 0.67360702 |
| 67 | MP0005334_abnormal_fat_pad | 0.66145428 |
| 68 | MP0003329_amyloid_beta_deposits | 0.64891184 |
| 69 | MP0003690_abnormal_glial_cell | 0.64866847 |
| 70 | MP0004130_abnormal_muscle_cell | 0.63812603 |
| 71 | MP0005257_abnormal_intraocular_pressure | 0.63355174 |
| 72 | MP0005266_abnormal_metabolism | 0.62836366 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.59894261 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.58663020 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.56317068 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.55610191 |
| 77 | MP0002249_abnormal_larynx_morphology | 0.55488388 |
| 78 | MP0005448_abnormal_energy_balance | 0.53318360 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.51915575 |
| 80 | MP0003878_abnormal_ear_physiology | 0.51915575 |
| 81 | MP0005395_other_phenotype | 0.51130775 |
| 82 | MP0003121_genomic_imprinting | 0.50481269 |
| 83 | MP0005023_abnormal_wound_healing | 0.49719765 |
| 84 | MP0002928_abnormal_bile_duct | 0.49637821 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47698834 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.47435579 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.47107928 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.46924023 |
| 89 | MP0006054_spinal_hemorrhage | 0.46567265 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.45888879 |
| 91 | MP0003718_maternal_effect | 0.45801902 |
| 92 | MP0003115_abnormal_respiratory_system | 0.45231002 |
| 93 | MP0002822_catalepsy | 0.44652063 |
| 94 | MP0008873_increased_physiological_sensi | 0.43377419 |
| 95 | MP0003724_increased_susceptibility_to | 0.42367260 |
| 96 | MP0008874_decreased_physiological_sensi | 0.42033302 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.41775554 |
| 98 | MP0003075_altered_response_to | 0.41715637 |
| 99 | MP0000858_altered_metastatic_potential | 0.41400571 |
| 100 | MP0003953_abnormal_hormone_level | 0.41348525 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.41132939 |
| 102 | MP0003436_decreased_susceptibility_to | 0.41067765 |
| 103 | MP0003632_abnormal_nervous_system | 0.40904493 |
| 104 | MP0009672_abnormal_birth_weight | 0.39251501 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.39212711 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.39169913 |
| 107 | MP0000920_abnormal_myelination | 0.38915397 |
| 108 | MP0002933_joint_inflammation | 0.38378115 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.38361303 |
| 110 | MP0005166_decreased_susceptibility_to | 0.37936657 |
| 111 | MP0008872_abnormal_physiological_respon | 0.37427120 |
| 112 | MP0003943_abnormal_hepatobiliary_system | 0.35457809 |
| 113 | MP0004883_abnormal_blood_vessel | 0.34793891 |
| 114 | MP0002796_impaired_skin_barrier | 0.34624160 |
| 115 | MP0002092_abnormal_eye_morphology | 0.34281384 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.34019079 |
| 117 | MP0002168_other_aberrant_phenotype | 0.33037907 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.32867430 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.32849942 |
| 120 | MP0000249_abnormal_blood_vessel | 0.32069557 |
| 121 | MP0004043_abnormal_pH_regulation | 0.32051472 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.31906901 |
| 123 | MP0009115_abnormal_fat_cell | 0.31750686 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.31655046 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.31007091 |
| 126 | MP0006292_abnormal_olfactory_placode | 0.30610064 |
| 127 | MP0004381_abnormal_hair_follicle | 0.30256554 |
| 128 | MP0001243_abnormal_dermal_layer | 0.30047788 |
| 129 | MP0006082_CNS_inflammation | 0.29770789 |
| 130 | MP0000579_abnormal_nail_morphology | 0.29464955 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.29428747 |
| 132 | MP0002970_abnormal_white_adipose | 0.29157403 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.28981489 |
| 134 | MP0004147_increased_porphyrin_level | 0.28341028 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.28051618 |
| 136 | MP0005164_abnormal_response_to | 0.27115714 |
| 137 | MP0002135_abnormal_kidney_morphology | 0.26642467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.38865060 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31327159 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.14412780 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.51728282 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47573522 |
| 6 | Xanthomatosis (HP:0000991) | 6.27175398 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.22601813 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.40153185 |
| 9 | Complement deficiency (HP:0004431) | 5.25133905 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.77417829 |
| 11 | Hyperammonemia (HP:0001987) | 4.62038835 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54461358 |
| 13 | Hyperglycinemia (HP:0002154) | 4.43310171 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34451160 |
| 15 | Ketosis (HP:0001946) | 4.31635248 |
| 16 | Epidermoid cyst (HP:0200040) | 4.31021889 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.28576388 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.24664224 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22507301 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.16489848 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13146331 |
| 22 | * Joint hemorrhage (HP:0005261) | 4.12730283 |
| 23 | Hyperglycinuria (HP:0003108) | 4.06089258 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.02618257 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02618257 |
| 26 | Fat malabsorption (HP:0002630) | 4.01431375 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.89212686 |
| 28 | Abnormality of complement system (HP:0005339) | 3.82768426 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77758639 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75728892 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58870391 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.52574904 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.40186263 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35966478 |
| 35 | Nephritis (HP:0000123) | 3.29820163 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27468492 |
| 37 | Purpura (HP:0000979) | 3.27256809 |
| 38 | Spontaneous abortion (HP:0005268) | 3.19354275 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14120378 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.12099270 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.09470958 |
| 42 | Ketoacidosis (HP:0001993) | 3.09043834 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.08044416 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.06484503 |
| 45 | Steatorrhea (HP:0002570) | 2.96306424 |
| 46 | Myocardial infarction (HP:0001658) | 2.85687795 |
| 47 | Metabolic acidosis (HP:0001942) | 2.83336784 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.82301247 |
| 49 | Gout (HP:0001997) | 2.77183449 |
| 50 | Acanthocytosis (HP:0001927) | 2.72477741 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.71464356 |
| 52 | Vascular calcification (HP:0004934) | 2.65655799 |
| 53 | Skin nodule (HP:0200036) | 2.65048957 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.63359194 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63359194 |
| 56 | Lethargy (HP:0001254) | 2.62949219 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.49414931 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.48379284 |
| 59 | Glomerulonephritis (HP:0000099) | 2.46766487 |
| 60 | Cholelithiasis (HP:0001081) | 2.44952857 |
| 61 | Osteomalacia (HP:0002749) | 2.44872569 |
| 62 | Spastic diplegia (HP:0001264) | 2.43731416 |
| 63 | Cerebral edema (HP:0002181) | 2.43124619 |
| 64 | Amyloidosis (HP:0011034) | 2.41480178 |
| 65 | Abnormality of carpal bone ossification (HP:0006257) | 2.41159389 |
| 66 | Irritability (HP:0000737) | 2.37818683 |
| 67 | Neonatal onset (HP:0003623) | 2.36888620 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.36394899 |
| 69 | Cholecystitis (HP:0001082) | 2.36394899 |
| 70 | Mitral stenosis (HP:0001718) | 2.35823940 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.35347182 |
| 72 | Gingival bleeding (HP:0000225) | 2.30510136 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30458975 |
| 74 | Malnutrition (HP:0004395) | 2.29847084 |
| 75 | Arthropathy (HP:0003040) | 2.28084028 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 2.26121072 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.23635376 |
| 78 | Enlarged kidneys (HP:0000105) | 2.22450611 |
| 79 | Esophageal varix (HP:0002040) | 2.20639040 |
| 80 | Thrombophlebitis (HP:0004418) | 2.20406005 |
| 81 | Poikilocytosis (HP:0004447) | 2.20283724 |
| 82 | Pulmonary embolism (HP:0002204) | 2.19293498 |
| 83 | Menorrhagia (HP:0000132) | 2.18632634 |
| 84 | Pancreatitis (HP:0001733) | 2.17957585 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.16479158 |
| 86 | Vomiting (HP:0002013) | 2.14740157 |
| 87 | Late onset (HP:0003584) | 2.14725640 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 2.09083185 |
| 89 | Brushfield spots (HP:0001088) | 2.06185811 |
| 90 | Broad alveolar ridges (HP:0000187) | 2.06157368 |
| 91 | Increased serum pyruvate (HP:0003542) | 2.05862892 |
| 92 | Rickets (HP:0002748) | 2.04781009 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 2.03993829 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01724226 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.01490912 |
| 96 | Potter facies (HP:0002009) | 2.00511281 |
| 97 | Facial shape deformation (HP:0011334) | 2.00511281 |
| 98 | Opisthotonus (HP:0002179) | 1.99929998 |
| 99 | Alkalosis (HP:0001948) | 1.99008486 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.96636400 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 1.96636400 |
| 102 | Bifid scrotum (HP:0000048) | 1.95856602 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 1.93874691 |
| 104 | Proximal tubulopathy (HP:0000114) | 1.93687710 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93454817 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 1.91360410 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89627746 |
| 108 | Flat acetabular roof (HP:0003180) | 1.89172985 |
| 109 | Hyperuricemia (HP:0002149) | 1.87239381 |
| 110 | Increased purine levels (HP:0004368) | 1.87239381 |
| 111 | Epistaxis (HP:0000421) | 1.86827803 |
| 112 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86333349 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.86090313 |
| 114 | Abnormality of glycolysis (HP:0004366) | 1.84489750 |
| 115 | Asymmetry of the thorax (HP:0001555) | 1.84218025 |
| 116 | Vaginal fistula (HP:0004320) | 1.83723143 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.80543790 |
| 118 | Renal cortical cysts (HP:0000803) | 1.80198989 |
| 119 | Abnormality of the lumbar spine (HP:0100712) | 1.80045083 |
| 120 | Glycosuria (HP:0003076) | 1.79906114 |
| 121 | Small epiphyses (HP:0010585) | 1.78999287 |
| 122 | Abnormal delivery (HP:0001787) | 1.78385524 |
| 123 | Joint swelling (HP:0001386) | 1.75295620 |
| 124 | Abnormal ossification of hand bones (HP:0005921) | 1.74825891 |
| 125 | Abnormal hand bone ossification (HP:0010660) | 1.74636432 |
| 126 | Gangrene (HP:0100758) | 1.64557925 |
| 127 | Hepatoblastoma (HP:0002884) | 1.63250846 |
| 128 | Widely patent fontanelles and sutures (HP:0004492) | 1.61364350 |
| 129 | Increased serum ferritin (HP:0003281) | 1.57927835 |
| 130 | Fair hair (HP:0002286) | 1.55011287 |
| 131 | Abnormality of the nasal septum (HP:0000419) | 1.53892544 |
| 132 | Broad palm (HP:0001169) | 1.53189485 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 1.49784443 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.49004969 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.49004969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.38963024 |
| 2 | FGFR4 | 4.73263589 |
| 3 | ERN1 | 4.39584068 |
| 4 | SIK1 | 4.36489317 |
| 5 | TAOK3 | 2.98140579 |
| 6 | INSRR | 2.95229443 |
| 7 | CDK12 | 2.83329277 |
| 8 | ERBB4 | 2.81042716 |
| 9 | TYRO3 | 2.27042468 |
| 10 | MAP2K4 | 2.24841089 |
| 11 | MST1R | 2.21712695 |
| 12 | PKN2 | 2.12802053 |
| 13 | MAPK11 | 1.99893542 |
| 14 | PIK3CA | 1.99533184 |
| 15 | PDGFRA | 1.92133447 |
| 16 | TRIB3 | 1.87138901 |
| 17 | FGFR1 | 1.85398656 |
| 18 | FLT3 | 1.82064648 |
| 19 | PIK3CG | 1.79342671 |
| 20 | TYK2 | 1.76910341 |
| 21 | LATS1 | 1.58482359 |
| 22 | DAPK2 | 1.56101928 |
| 23 | PTK6 | 1.53015584 |
| 24 | ABL2 | 1.49980833 |
| 25 | AKT3 | 1.41251729 |
| 26 | NEK9 | 1.40521589 |
| 27 | KDR | 1.33709377 |
| 28 | WNK1 | 1.31640121 |
| 29 | EEF2K | 1.30279875 |
| 30 | SIK2 | 1.27719854 |
| 31 | JAK2 | 1.23869892 |
| 32 | GRK6 | 1.22582764 |
| 33 | FGFR2 | 1.21268518 |
| 34 | FRK | 1.21047048 |
| 35 | DDR2 | 1.15427938 |
| 36 | MAP3K7 | 1.15304515 |
| 37 | PINK1 | 1.12767562 |
| 38 | PRKAA2 | 1.11352069 |
| 39 | MAP2K3 | 1.10456840 |
| 40 | MAP3K2 | 1.07639417 |
| 41 | SMG1 | 1.07057241 |
| 42 | STK38L | 1.03905249 |
| 43 | ERBB2 | 1.03674477 |
| 44 | MAP3K10 | 1.03319106 |
| 45 | EIF2AK1 | 1.00260823 |
| 46 | TBK1 | 0.99882557 |
| 47 | NTRK3 | 0.96017085 |
| 48 | JAK1 | 0.95702325 |
| 49 | EPHB1 | 0.95216528 |
| 50 | MET | 0.93398952 |
| 51 | MAPK4 | 0.92817996 |
| 52 | MAP3K3 | 0.90831548 |
| 53 | MAP3K11 | 0.90492752 |
| 54 | PRKCZ | 0.90286262 |
| 55 | MAP3K14 | 0.86296120 |
| 56 | MAPK15 | 0.85803135 |
| 57 | CDK7 | 0.84290711 |
| 58 | CDK6 | 0.81563153 |
| 59 | TIE1 | 0.81234710 |
| 60 | EPHA2 | 0.80959003 |
| 61 | DYRK1B | 0.80517482 |
| 62 | MAPK12 | 0.79096743 |
| 63 | FGR | 0.78292072 |
| 64 | PRKACG | 0.77853488 |
| 65 | EPHA3 | 0.74690499 |
| 66 | GSK3A | 0.72851364 |
| 67 | MAPKAPK3 | 0.69262015 |
| 68 | CDC42BPA | 0.68626973 |
| 69 | PRKAA1 | 0.66881423 |
| 70 | SGK1 | 0.66861882 |
| 71 | CSK | 0.66252240 |
| 72 | CAMK2G | 0.65750075 |
| 73 | SGK3 | 0.65673176 |
| 74 | PTK2 | 0.64187387 |
| 75 | TGFBR2 | 0.63598919 |
| 76 | CSNK1E | 0.63238739 |
| 77 | MAP2K6 | 0.60924688 |
| 78 | RPS6KB1 | 0.60378019 |
| 79 | RIPK1 | 0.60002720 |
| 80 | KSR2 | 0.58292614 |
| 81 | CAMK1D | 0.58150526 |
| 82 | PDPK1 | 0.53730751 |
| 83 | IRAK3 | 0.52454056 |
| 84 | MAPK7 | 0.50387212 |
| 85 | FGFR3 | 0.50166746 |
| 86 | CSF1R | 0.49827309 |
| 87 | IKBKE | 0.49466111 |
| 88 | TAOK2 | 0.49185228 |
| 89 | SGK2 | 0.47903270 |
| 90 | PRKCQ | 0.47707732 |
| 91 | MATK | 0.47043331 |
| 92 | SGK223 | 0.45863933 |
| 93 | SGK494 | 0.45863933 |
| 94 | CDK4 | 0.45730298 |
| 95 | BRSK1 | 0.43780270 |
| 96 | MAP2K1 | 0.43399309 |
| 97 | GRK1 | 0.43331809 |
| 98 | CSNK1G1 | 0.43074648 |
| 99 | MAP3K5 | 0.41848997 |
| 100 | SRC | 0.41802349 |
| 101 | CSNK1D | 0.41599996 |
| 102 | PBK | 0.40439164 |
| 103 | PRKCG | 0.40174990 |
| 104 | EPHA4 | 0.39945489 |
| 105 | IGF1R | 0.39391477 |
| 106 | MTOR | 0.37025863 |
| 107 | RET | 0.36384713 |
| 108 | BRD4 | 0.35680990 |
| 109 | ICK | 0.35355190 |
| 110 | WNK4 | 0.34726543 |
| 111 | WNK3 | 0.34310071 |
| 112 | PRKG1 | 0.34203978 |
| 113 | PKN1 | 0.33454922 |
| 114 | MAP3K6 | 0.33394137 |
| 115 | EGFR | 0.32653473 |
| 116 | PDK1 | 0.32638992 |
| 117 | RPS6KA3 | 0.32586721 |
| 118 | CSNK2A2 | 0.32342473 |
| 119 | MAP3K13 | 0.32244015 |
| 120 | NEK2 | 0.31977932 |
| 121 | MARK2 | 0.31405830 |
| 122 | BCR | 0.30797651 |
| 123 | MAP3K1 | 0.30762117 |
| 124 | CAMK4 | 0.29173731 |
| 125 | CSNK2A1 | 0.28993478 |
| 126 | MAPK3 | 0.27154584 |
| 127 | NLK | 0.26726869 |
| 128 | CDK8 | 0.26275614 |
| 129 | PDK3 | 0.26266361 |
| 130 | PDK4 | 0.26266361 |
| 131 | PRKCA | 0.25738852 |
| 132 | BRSK2 | 0.25537903 |
| 133 | MAP2K2 | 0.24065793 |
| 134 | PDGFRB | 0.23616215 |
| 135 | PAK3 | 0.23346164 |
| 136 | BMX | 0.21864036 |
| 137 | PRKACA | 0.21688087 |
| 138 | CDK9 | 0.20838459 |
| 139 | NTRK2 | 0.20378206 |
| 140 | CSNK1G2 | 0.20115314 |
| 141 | LATS2 | 0.19972892 |
| 142 | PRKCB | 0.19317030 |
| 143 | NEK1 | 0.18552695 |
| 144 | PRKACB | 0.18269010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41536218 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64409419 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39428793 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33778389 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06997169 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74156457 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71674911 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66484878 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64176069 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61402476 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50381148 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41895762 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24094286 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23559383 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.08729132 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05960156 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96641899 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89892188 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87238502 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84836390 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83678973 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83561798 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81833526 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76040488 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74704295 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73885530 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72074794 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69350745 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61424943 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60500357 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60288700 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58252576 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57978767 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54989924 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.47736044 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45558895 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41805913 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41321813 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38019245 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32949076 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32272357 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25499474 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23694267 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22659615 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22363743 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18802803 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17276624 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16906803 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14000198 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06303552 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04170608 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03927154 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02430877 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01458414 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99942725 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96929543 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94403549 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92942047 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86166881 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.83418199 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78882013 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72724637 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69772816 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68429323 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60394831 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54957046 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.52337033 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47640314 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47071695 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34862555 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.32777589 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30448903 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27828504 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26559306 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26215007 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23025566 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.22129970 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.20972776 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20642635 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20616011 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14684824 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11068589 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08693997 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01368098 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2491175 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2443991 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2420338 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2250137 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2056570 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1815959 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1754894 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1748652 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1711677 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1683609 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1681439 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1575054 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1530231 |
| 98 | Lysosome_Homo sapiens_hsa04142 | -0.1464977 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1452411 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1387524 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1302049 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1293294 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1172898 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1118241 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1024593 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0917230 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0842303 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0661867 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0331678 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0328489 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.0122901 |

